Help us to improve the website - give your feedback.

Rolling Action Plan (RAP) for UK REACH 2023-2025

  1. In accordance with Article 44 of UK REACH and the criteria outlined in the Approach to substance evaluation in UK REACH[34], the UK rolling action plan (RAP) is updated as shown in table 1.
  2. In our approach to substance selection, we have sought to complement rather than replicate evaluation work that has been or will be performed by other regulatory regimes (such as via EU REACH), and at the same time avoid unnecessary duplication of work where testing is indicated at the outcome of evaluation. The intention is to increase our overall understanding of the hazard and risk profile of the priority substances.
  3. Selection of substances for inclusion in the RAP is based on the hazard profile of substances and their exposure potential, including the quantities that are supplied. We consider information from the following sources to identify priorities:
    • the GB specific registration data within the UK database (Comply with UK REACH)
    • UK REACH processes (such as dossier evaluation)
    • other intelligence such as the Environment Agency’s Prioritisation and Early Warning System (PEWS) and horizon scanning of other regimes, both domestic (like GB CLP) and international (for example EU REACH and regulatory systems from other countries)
  4. Substance evaluation[35] will be conducted where a potential concern has been identified. The evaluation will determine if a conclusion on the concern can be drawn from the available data. If a conclusion cannot be drawn, we can (as the Agency for UK REACH) request registrants provide additional information to clarify the concern. In such cases, if they arise, deadlines will be set by which the information shall be provided.
  5. The initial grounds for concern are described briefly in the RAP and further detail is provided in the specific justification document. The indication of the initial grounds for concern does not limit the scope of the evaluation, other areas of concern identified during an assessment may also be included.
  6. Using the sources referred to in paragraph 3, we have identified one substance for evaluation in 2023 (see Table 1). In 2024/25 we will focus on poly- and perfluoroalkyl substances (PFAS) and consider recommendations from broader scoping activities, regulatory management options analyses (RMOAs) and the Environment Agency’s updated report on flame retardants when published.

Table 1: Substances proposed for inclusion in the rolling action plan (RAP) for UK REACH 2023-2025

Use the links in the table to read the justification for the inclusion of the substance.

Year Substance EC No CAS No Initial grounds for concern
2023 N-butylbenzenesulphonamide (PDF) [36] 222-823-6 3622-84-2 Environment: suspected to be persistent, and for which environmental monitoring data or screening laboratory data (such as organic-water partitioning coefficient) indicate the likelihood of widespread distribution in the environment

Exposure: widespread detection in environmental monitoring
2024 PFAS, subject to further assessment - - Recommendation from the UK REACH RMOA for PFAS (PDF) [37]

View the PFAS RMOA Annexes (PDF) [38]
2025 To be agreed (by 31 May 2025) - - -

Link URLs in this page

  1. UK REACHhttps://www.hse.gov.uk/reach/index.htm
  2. REACH Basicshttps://www.hse.gov.uk/reach/basics.htm
  3. UK REACH explainedhttps://www.hse.gov.uk/reach/about.htm
  4. Submit dossiershttps://www.hse.gov.uk/reach/using-comply-with-uk-reach.htm
  5. Roles and responsibilitieshttps://www.hse.gov.uk/reach/roles.htm
  6. Fees and chargeshttps://www.hse.gov.uk/reach/fees-and-charges-table.htm
  7. Reporting a concernhttps://www.hse.gov.uk/reach/enforcement.htm
  8. Authorisation overviewhttps://www.hse.gov.uk/reach/authorisation.htm
  9. Authorisation listhttps://www.hse.gov.uk/reach/authorisation-list.htm
  10. Applying for a UK REACH Authorisationhttps://www.hse.gov.uk/reach/new-authorisation.htm
  11. Grandfathering EU authorisationshttps://www.hse.gov.uk/reach/grandfathering-authorisation.htm
  12. Awaiting ECHA opinion on authorisationhttps://www.hse.gov.uk/reach/authorisation127ga.htm
  13. Awaiting EU application authorisationhttps://www.hse.gov.uk/reach/authorisation127g.htm
  14. SVHCshttps://www.hse.gov.uk/reach/svhc.htm
  15. EU REACH authorisations downstream usershttps://www.hse.gov.uk/reach/authorisation127h.htm
  16. Evaluationhttps://www.hse.gov.uk/reach/evaluation.htm
  17. Registration overviewhttps://www.hse.gov.uk/reach/reach-registration.htm
  18. New registrationhttps://www.hse.gov.uk/reach/new-registration.htm
  19. Grandfathering EU registrationshttps://www.hse.gov.uk/reach/grandfathering-registrations.htm
  20. Downstream user notificationhttps://www.hse.gov.uk/reach/duin.htm
  21. DUIN Templatehttps://www.hse.gov.uk/reach/duin-template.htm
  22. Lead registrants in UK REACHhttps://www.hse.gov.uk/reach/lead-registrant.htm
  23. Research and Development (PPORD) overviewhttps://www.hse.gov.uk/reach/ppord.htm
  24. Research and Development (PPORD) exemptionhttps://www.hse.gov.uk/reach/new-ppord.htm
  25. Northern Ireland Notification (NIP-NOTS)https://www.hse.gov.uk/reach/northern-ireland.htm
  26. Restrictionshttps://www.hse.gov.uk/reach/restrictions.htm
  27. Reports and planshttps://www.hse.gov.uk/reach/reports-plans.htm
  28. Resources overviewhttps://www.hse.gov.uk/reach/resources.htm
  29. UK chemicals helplinehttps://www.hse.gov.uk/reach/contact.htm
  30. Get involved in UK REACHhttps://www.hse.gov.uk/reach/get-involved.htm
  31. Glossaryhttps://www.hse.gov.uk/reach/definitions.htm
  32. EU REACH linkshttps://www.hse.gov.uk/reach/eu-reach-links.htm
  33. Independent scientific advicehttps://www.hse.gov.uk/reach/reach-independent-scientific-expert-pool.htm
  34. Approach to substance evaluation in UK REACHhttps://www.hse.gov.uk/reach/substance-evaluation-approach.htm
  35. Substance evaluationhttps://www.hse.gov.uk/reach/substance-evaluation-approach.htm
  36. N-butylbenzenesulphonamidehttps://www.hse.gov.uk/reach/reports/rap/docs/rap-justification-n-butylbenzenesulphonamide.pdf
  37. Recommendation from the UK REACH RMOA for PFAShttps://www.hse.gov.uk/reach/assets/docs/pfas-rmoa.pdf
  38. View the PFAS RMOA Annexeshttps://www.hse.gov.uk/reach/assets/docs/pfas-rmoa-annexes.pdf

Is this page useful?

Updated 2023-11-21